HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

No free lunches: balancing bleeding and efficacy with ticagrelor.

AuthorsJames A de Lemos, Emmanouil S Brilakis
JournalEuropean heart journal (Eur Heart J) Vol. 32 Issue 23 Pg. 2919-21 (Dec 2011) ISSN: 1522-9645 [Electronic] England
PMID22096089 (Publication Type: Comment, Editorial)
Chemical References
  • Platelet Aggregation Inhibitors
  • Purinergic P2 Receptor Antagonists
  • clopidogrel
  • Ticagrelor
  • Adenosine
  • Ticlopidine
Topics
  • Acute Coronary Syndrome (prevention & control)
  • Adenosine (adverse effects, analogs & derivatives)
  • Female
  • Hemorrhage (chemically induced)
  • Humans
  • Male
  • Platelet Aggregation Inhibitors (adverse effects)
  • Purinergic P2 Receptor Antagonists (adverse effects)
  • Ticlopidine (adverse effects, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: